Involvement of both the SNS and HPA pathways in poststroke immunosuppression was further demonstrated in experiments blocking the respective pathways using propranolol and the glucocorticoid receptor inhibitor RU486, which resulted in a reduction of lymphocyte apoptosis and monocyte deactivation after experimental stroke (Prass et al, 2003). This evidence concerns the gene NR3C1 and stroke disorder.